UL Stock Analysis: Unilever | NYSE
Household & Personal Products | NYSE, USA | Market Cap: 130.935m USD | 12M Return: -3% | US9047678035 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 173M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Unilever PLC is a multinational fast-moving consumer goods (FMCG) company headquartered in London, operating across Asia Pacific, Africa, the Americas, and Europe through four segments: Beauty & Wellbeing, Personal Care, Home Care, and Foods. Its portfolio covers everyday essentials such as shampoo, skin care, soap, deodorants, oral care, laundry and cleaning products, soups, seasonings, and condiments, marketed under widely recognized brands including Dove, Hellmanns, Knorr, Vaseline, TRESemmé, and Sunsilk. Founded in 1860, the company trades on the NYSE as an American Depositary Receipt (ADR) under the ticker UL. As a Consumer Staples issuer classified in the Personal Care Products sub-industry, Unilevers business model is built on high-volume, recurring demand for household and personal care items, which typically generates stable cash flows across economic cycles.
- Ice cream spin-off creates focused faster-growing staples entity
- Beauty & Wellbeing premium brands drive margin expansion
- Emerging markets currency headwinds pressure reported revenue growth
| Net Income: 5.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.69 > 1.0 |
| NWC/Revenue: -16.36% < 20% (prev -9.89%; Δ -6.48% < -1%) |
| CFO/TA 0.11 > 3% & CFO 8.53b > Net Income 5.88b |
| Net Debt (27.6b) to EBITDA (10.5b): 2.62 < 3 |
| Current Ratio: 0.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.18b) vs 12m ago -13.05% < -2% |
| Gross Margin: 41.56% > 18% (prev 44.14%; Δ -2.58% > 0.5%) |
| Asset Turnover: 59.96% > 50% (prev 78.65%; Δ -18.69% > 0%) |
| Interest Coverage Ratio: 9.13 > 6 (EBIT TTM 9.42b / Interest Expense TTM 1.03b) |
| A: -0.10 (Total Current Assets 21.4b - Total Current Liabilities 28.9b) / Total Assets 76.9b |
| B: 0.60 (Retained Earnings 45.9b / Total Assets 76.9b) |
| C: 0.12 (EBIT TTM 9.42b / Avg Total Assets 76.5b) |
| D: 0.28 (Book Value of Equity 16.2b / Total Liabilities 58.6b) |
| Altman-Z'' = 2.42 = A |
| DSRI: 1.73 (Receivables 10.2b/7.69b, Revenue 45.8b/59.8b) |
| GMI: 1.06 (GM 44.14% / 41.56%) |
| AQI: 0.99 (AQ_t 0.60 / AQ_t-1 0.60) |
| SGI: 0.77 (Revenue 45.8b / 59.8b) |
| TATA: -0.03 (NI 5.88b - CFO 8.53b) / TA 76.9b) |
| Beneish M = -2.54 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 61.94 with a total of 2,978,862 shares traded. Over the past week, the price has changed by +3.96%, over one month by -2.52%, over three months by +1.00% and over the past year by -2.98%.
Current recommended Stop Loss: 60.40 (which is 2.5% or 1.7 ATR below the current price).
Unilever has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy UL.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 71.6 | 15.6% |
Market Cap EUR = 117b (131b USD * 0.89279997348785 USD.EUR)
P/E Trailing = 12.1116
P/E Forward = 16.3934
P/S = 2.5866
P/B = 7.2902
P/EG = 10.9272
Revenue TTM = 45.8b EUR
EBIT TTM = 9.42b EUR
EBITDA TTM = 10.5b EUR
Long Term Debt = 24.1b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 8.14b EUR (from shortTermDebt, last quarter)
Debt = 33.4b EUR (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 27.6b EUR (calculated: Debt 33.4b - CCE 5.87b)
Enterprise Value = 144b EUR (117b + Debt 33.4b - CCE 5.87b)
Interest Coverage Ratio = 9.13 (Ebit TTM 9.42b / Interest Expense TTM 1.03b)
EV/FCF = 19.96x (Enterprise Value 144b / FCF TTM 7.24b)
FCF Yield = 5.01% (FCF TTM 7.24b / Enterprise Value 144b)
FCF Margin = 15.78% (FCF TTM 7.24b / Revenue TTM 45.8b)
Net Margin = 12.83% (Net Income TTM 5.88b / Revenue TTM 45.8b)
Gross Margin = 41.56% ((Revenue TTM 45.8b - Cost of Revenue TTM 26.8b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 1.88 (Enterprise Value 144b / Total Assets 76.9b)
Interest Expense / Debt = 3.09% (Interest Expense 1.03b / Debt 33.4b)
Taxrate = 31.29% (2.58b / 8.23b)
NOPAT = 6.47b (EBIT 9.42b * (1 - 31.29%))
Current Ratio = 0.74 (Total Current Assets 21.4b / Total Current Liabilities 28.9b)
Debt / Equity = 2.06 (Debt 33.4b / totalStockholderEquity, last quarter 16.2b)
Debt / EBITDA = 2.62 (Net Debt 27.6b / EBITDA 10.5b)
Debt / FCF = 3.81 (Net Debt 27.6b / FCF TTM 7.24b)
Total Stockholder Equity = 17.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.69% (Net Income 5.88b / Total Assets 76.9b)
RoE = 33.85% (Net Income TTM 5.88b / Total Stockholder Equity 17.4b)
RoCE = 22.71% (EBIT 9.42b / Capital Employed (Equity 17.4b + L.T.Debt 24.1b))
RoIC = 12.01% (NOPAT 6.47b / Invested Capital 53.9b)
WACC = 4.31% (E(117b)/V(150b) * Re(4.93%) + D(33.4b)/V(150b) * Rd(3.09%) * (1-Tc(0.31)))
Discount Rate = 4.93% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -83.27 | Cagr: -7.34%
[DCF] Terminal Value 76.58% ; FCFF base≈6.99b ; Y1≈7.56b ; Y5≈9.29b
[DCF] Fair Price = 53.27 (EV 142b - Net Debt 27.6b = Equity 115b / Shares 2.15b; r=8.35% [WACC [floored]]; 5y FCF grow 9.30% → 2.50% )
EPS Correlation: -19.39 | EPS CAGR: -5.38% | SUE: 0.0 | # QB: 0
Revenue Correlation: -11.69 | Revenue CAGR: -1.84% | SUE: 0.86 | # QB: 1
EPS current Quarter (2026-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2025-12-31): EPS=2.94 | Chg30d=+2.36% | Revisions=+25% | GrowthEPS=-12.3% | GrowthRev=-16.8%
EPS next Year (2026-12-31): EPS=3.24 | Chg30d=+1.65% | Revisions=+0% | GrowthEPS=+5.2% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: +25% (up=1, down=0)